Biotech / PharmaPittsburgh

HexemBio

Biotech / Pharma

HexemBio is a biotechnology company developing regenerative therapies based on its Synthetic Human Yolk Sac technology, designed to rejuvenate aging blood stem cells. The company launched in 2026 with a $10.4M seed round led by Draper Associates. It aims to create the first scalable and reproducible rejuvenation therapy targeting early developmental cell states.

Founded

Region

Pittsburgh

Investors

Innovation Works

People

About Pittsburgh

Pittsburgh's tech economy grew out of Carnegie Mellon's robotics program, one of the oldest and deepest in the country, with the University of Pittsburgh's own research base sitting right alongside it — two major universities anchoring one relatively compact city. It's also a place that didn't start as a tech hub at all: this was steel country for a century, and that engineering-and-manufacturing inheritance still shows up in what the region builds — robotics, autonomy, and deep tech that comes out of hard industrial know-how, not a recent software boom.

Region Stats

Total firms 299

VC / investors 6

Companies 286

Universities 7

Known For

Robotics

Autonomy

Deep Tech